Drug Type Autologous CAR-T |
Synonyms LB 2101, LB-2101, LB2101 |
Target |
Action modulators |
Mechanism GPC3 modulators(Glypican-3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Liver Cancer | Preclinical | - | - | |
| Lung Cancer | Preclinical | - | - |





